Forteo (teriparatide) is a brand-name medication that doctors may prescribe to treat osteoporosis. The drug uses proteins to enhance bone strength and promote the development of new bone tissue. You ...

Tears in the shoulder's rotator cuff, a common sports injury, are painful and restricting. New research shows an approved therapy for osteoporosis, Forteo, may speed healing and improve patient ...

Eli Lilly and Company LLY today presented data comparing the effects of FORTEO and zoledronic acid on transiliac crest bone biopsies at six months in postmenopausal women with osteoporosis, based on ...

In a head-to-head comparison of the two drugs, Forteo increased lumbar spine density measurements by 7.2 percent compared to 3.4 percent for Fosamax, and it boosted hip density measurements by 3.8 ...

Eli Lilly and Co. has won U.S. regulatory approval to market its slow-selling osteoporosis drug Forteo for a new use, Lilly announced today. Lilly can now promote Forteo as a therapy for men and women ...

In premenopausal women with idiopathic osteoporosis, post-Forteo antiresorptive treatment may be needed to maintain Forteo-associated gains in bone mineral density, according to recent study findings.

Please provide your email address to receive an email when new articles are posted on . Forteo promotes rapid bone formation in the femoral neck, with pronounced effects in cancellous and endocortical ...